• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elicio Therapeutics, Inc. - Common Stock (NQ:ELTX)

4.710 +4.710 (+2354900.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 51,120,454
Open 0.0003
Bid (Size) 4.050 (400)
Ask (Size) 4.070 (4,800)
Prev. Close 0.0002
Today's Range 2.860 - 6.640
52wk Range 2.660 - 16.00
Shares Outstanding 29,798,399
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which stocks are moving after the closing bell on Wednesday? ↗
June 17, 2026
Via Chartmill
Top movers in Wednesday's session ↗
June 17, 2026
Via Chartmill

Performance

YTD
-41.5%
-41.5%
1 Month
-50.8%
-50.8%
3 Month
-59.7%
-59.7%
6 Month
-40.2%
-40.2%
1 Year
-40.8%
-40.8%

More News

Read More
News headline image
Elicio Therapeutics Reports Multiple Complete Responses After ELI-002 7P Treatment and Subsequent Therapy with Checkpoint Inhibition in Metastatic mKRAS Pancreatic Cancer
June 17, 2026
From Elicio Therapeutics Inc.
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
June 16, 2026
Via Chartmill
Elicio Therapeutics (NASDAQ:ELTX) Q1 2026 Results Show Extended Cash Runway Ahead of Key Phase 2 Data Readout ↗
May 11, 2026
Via Chartmill
Monday's session: top gainers and losers ↗
June 15, 2026
Via Chartmill
Gapping stocks in Monday's session ↗
June 15, 2026
Via Chartmill
Monday's pre-market session: top gainers and losers ↗
June 15, 2026
Via Chartmill
News headline image
Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer
June 15, 2026
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology
June 01, 2026
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 11, 2026
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics to Present at the Bank of America Healthcare Conference
April 30, 2026
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Reports Inducement Grants
April 16, 2026
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Reports Inducement Grants
March 17, 2026
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
March 12, 2026
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
February 25, 2026
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Reports Inducement Grants
February 18, 2026
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Reports Inducement Grants
January 16, 2026
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Reports Inducement Grants
December 16, 2025
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial
December 11, 2025
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer
November 19, 2025
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
November 13, 2025
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC
November 07, 2025
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics to Present Clinical and Preclinical Data at the SITC 2025 Annual Meeting
November 03, 2025
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Reports Robust T cell Responses Across Diverse HLA backgrounds in Ongoing Phase 2 AMPLIFY-7P Trial
October 27, 2025
From Elicio Therapeutics Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Elicio Therapeutics, Inc. - Common Stock publicly traded?
Yes, Elicio Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Elicio Therapeutics, Inc. - Common Stock trade on?
Elicio Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Elicio Therapeutics, Inc. - Common Stock?
The ticker symbol for Elicio Therapeutics, Inc. - Common Stock is ELTX on the Nasdaq Stock Market
What is the current price of Elicio Therapeutics, Inc. - Common Stock?
The current price of Elicio Therapeutics, Inc. - Common Stock is 4.710
When was Elicio Therapeutics, Inc. - Common Stock last traded?
The last trade of Elicio Therapeutics, Inc. - Common Stock was at 06/17/26 04:00 PM ET
What is the market capitalization of Elicio Therapeutics, Inc. - Common Stock?
The market capitalization of Elicio Therapeutics, Inc. - Common Stock is 140.35M
How many shares of Elicio Therapeutics, Inc. - Common Stock are outstanding?
Elicio Therapeutics, Inc. - Common Stock has 140M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap